Genentech, Inc. · South San Francisco, CA United States
Company Description
Phone: 650-225-1000
Fax: 650-225-6000
Rankings
- #75 in FT Global 500
View Genentech, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window "The few, the proud, the profitable" could be Genentech's motto. One of the world's most successful biotechs (in an industry full of money-losers), the firm has three billion-dollar blockbusters: Rituxan, which fights non-Hodgkin's lymphoma; Avastin, a treatment for colorectal, breast, and lung cancers; and Herceptin for breast cancer. Lung cancer drug Tarceva rounds out the company's oncology portfolio. Genentech's other marketed drugs include age-related macular degeneration treatment Lucentis, human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Swiss drugmaker Roche , which previously owned a majority stake in the firm, took full ownership of Genentech in 2009. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Genentech, Inc. Financials
| Company Type | Subsidiary Headquarters |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $13,418.0 |
| Employees | 11,174 |
Genentech, Inc. Executives
71 executives listed for Genentech, Inc.'s South San Francisco, CA location.
| Title | Name & Bio | Contact |
| CEO | Ian Clark | Network |
| CEO | Pascal Soriot | Network |
| CFO | Steve Krognes | Network |
Competition
Competitive Landscape for Genentech, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Genentech, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!